Lansforsakringar Fondforvaltning AB (publ)
Position in RVMD — Revolution Medicines, Inc.
CIK 2059323
Stockholm, V7
Position in RVMD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,072,217
New position
Shares Held
48,442
first reported quarter
Ownership
0.023%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#202
of 687 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Lansforsakringar Fondforvaltning AB (publ) holds $105,727,306 across 11 Biotechnology names. RVMD ranks #4 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
79,627 | $39,553,119 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
31,436 | $19,601,603 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
41,157 | $12,389,491 | |
| 4 | RVMD |
Revolution Medicines, Inc.
This page
|
48,442 | $9,072,217 | |
| 5 | RPRX |
Royalty Pharma plc
|
161,125 | $9,034,278 | |
| 6 | INSM |
INSMED Inc
|
63,437 | $6,763,652 | |
| 7 | INCY |
Incyte Corp
|
47,223 | $5,353,199 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
123,352 | $2,680,317 |
All Filings in RVMD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,072,217 | 48,442 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||